909110-25-4
Chemical Structure
Baminercept
Synonym(s): BG 9924; TT-47
- CAS No.: 909110-25-4
- Formula:N/A
- Molecular Weight:(93.76 kDa)
IUPAC Name: 1-(((tert-butyldimethylsilyl)oxy)methyl)cyclobutane-1-carbonitrile
SMILES: [Baminercept]
Biological Activity:
Baminercept (BG 9924; TT-47) is an Ig fusion protein targeting the lymphotoxin β receptor (LTβR). Baminercept effectively regulates subsets of circulating immune cells by inhibiting LIGHT, LT-α1β2 and their receptors. Baminercept also increases blood lymphocyte counts and reduces plasma CXCL13 levels. Baminercept carries a high risk of hepatotoxicity. Baminercept can be used in research on rheumatoid arthritis and primary Sjögren's syndrome[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Baminercept | 99.97% | Baminercept (BG 9924; TT-47) is an Ig fusion protein targeting the lymphotoxin β receptor (LTβR). Baminercept effectively regulates subsets of circulating immune cells by inhibiting LIGHT, LT-α1β2 and their receptors. Baminercept also increases blood lymphocyte counts and reduces plasma CXCL13 levels. Baminercept carries a high risk of hepatotoxicity. Baminercept can be used in research on rheumatoid arthritis and primary Sjögren's syndrome. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Bienkowska J, et al. Lymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritis. PLoS One. 2014;9(11):e112545. Published 2014 Nov 18. [Content Brief]
- [2]. St. Clair E W, et al. Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double‐Blind, Placebo‐Controlled Trial[J]. Arthritis & Rheumatology, 2018, 70(9): 1470-1480.
Keywords
